These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 14634080)
1. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. D'Souza WN; Lefrançois L J Immunol; 2003 Dec; 171(11):5727-35. PubMed ID: 14634080 [TBL] [Abstract][Full Text] [Related]
2. Evidence of a novel IL-2/15R beta-targeted cytokine involved in homeostatic proliferation of memory CD8+ T cells. Kamimura D; Ueda N; Sawa Y; Hachida S; Atsumi T; Nakagawa T; Sawa S; Jin GH; Suzuki H; Ishihara K; Murakami M; Hirano T J Immunol; 2004 Nov; 173(10):6041-9. PubMed ID: 15528339 [TBL] [Abstract][Full Text] [Related]
3. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2. Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902 [TBL] [Abstract][Full Text] [Related]
4. Cytokine deprivation of naive CD8+ T cells promotes minimal cell cycling but maximal cytokine synthesis and autonomous proliferation subsequently: a mechanism of self-regulation. Sad S; Krishnan L J Immunol; 1999 Sep; 163(5):2443-51. PubMed ID: 10452979 [TBL] [Abstract][Full Text] [Related]
5. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. Schluns KS; Williams K; Ma A; Zheng XX; Lefrançois L J Immunol; 2002 May; 168(10):4827-31. PubMed ID: 11994430 [TBL] [Abstract][Full Text] [Related]
6. Disparate in vitro and in vivo requirements for IL-2 during antigen-independent CD8 T cell expansion. Wong P; Pamer EG J Immunol; 2004 Feb; 172(4):2171-6. PubMed ID: 14764683 [TBL] [Abstract][Full Text] [Related]
7. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. Valenzuela J; Schmidt C; Mescher M J Immunol; 2002 Dec; 169(12):6842-9. PubMed ID: 12471116 [TBL] [Abstract][Full Text] [Related]
8. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348 [TBL] [Abstract][Full Text] [Related]
9. Frontline: An in-depth evaluation of the production of IL-2 by antigen-specific CD8 T cells in vivo. D'Souza WN; Lefrançois L Eur J Immunol; 2004 Nov; 34(11):2977-85. PubMed ID: 15384078 [TBL] [Abstract][Full Text] [Related]
10. IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells. Chang J; Cho JH; Lee SW; Choi SY; Ha SJ; Sung YC J Immunol; 2004 Mar; 172(5):2818-26. PubMed ID: 14978082 [TBL] [Abstract][Full Text] [Related]
11. Priming in the presence of IL-10 results in direct enhancement of CD8+ T cell primary responses and inhibition of secondary responses. Kang SS; Allen PM J Immunol; 2005 May; 174(9):5382-9. PubMed ID: 15843536 [TBL] [Abstract][Full Text] [Related]
12. IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. Blachère NE; Morris HK; Braun D; Saklani H; Di Santo JP; Darnell RB; Albert ML J Immunol; 2006 Jun; 176(12):7288-300. PubMed ID: 16751372 [TBL] [Abstract][Full Text] [Related]
13. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines. Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520 [TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes. Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391 [TBL] [Abstract][Full Text] [Related]
16. Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response. Liu Z; Lefrançois L J Immunol; 2004 Oct; 173(7):4324-30. PubMed ID: 15383561 [TBL] [Abstract][Full Text] [Related]
17. IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells. Alves NL; Arosa FA; van Lier RA J Immunol; 2005 Jul; 175(2):755-62. PubMed ID: 16002671 [TBL] [Abstract][Full Text] [Related]
18. IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. Geiselhart LA; Humphries CA; Gregorio TA; Mou S; Subleski J; Komschlies KL J Immunol; 2001 Mar; 166(5):3019-27. PubMed ID: 11207251 [TBL] [Abstract][Full Text] [Related]
19. Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens. Ramanathan S; Dubois S; Gagnon J; Leblanc C; Mariathasan S; Ferbeyre G; Rottapel R; Ohashi PS; Ilangumaran S J Immunol; 2010 Jul; 185(1):357-66. PubMed ID: 20519645 [TBL] [Abstract][Full Text] [Related]
20. Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses. Dercamp C; Chemin K; Caux C; Trinchieri G; Vicari AP Cancer Res; 2005 Sep; 65(18):8479-86. PubMed ID: 16166328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]